
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13013785
[patent_doc_number] => 10030000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Acesulfame potassium compositions and processes for producing same
[patent_app_type] => utility
[patent_app_number] => 15/704419
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15817
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15704419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/704419 | Acesulfame potassium compositions and processes for producing same | Sep 13, 2017 | Issued |
Array
(
[id] => 14534399
[patent_doc_number] => 20190202821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/331916
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331916 | Monocyclic compounds useful as GPR120 modulators | Sep 10, 2017 | Issued |
Array
(
[id] => 13717007
[patent_doc_number] => 20170369458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION
[patent_app_type] => utility
[patent_app_number] => 15/700773
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/700773 | Method for prevention of premature polymerization | Sep 10, 2017 | Issued |
Array
(
[id] => 14119231
[patent_doc_number] => 10246462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Chemokine receptor modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/700040
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 153709
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 948
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/700040 | Chemokine receptor modulators and uses thereof | Sep 7, 2017 | Issued |
Array
(
[id] => 12092515
[patent_doc_number] => 20170349609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'NOVEL CRYSTALLINE FORM OF CEFAMANDOLE NAFATE COMPOUND, PREPARATION AND PREPARING METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/687359
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3117
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687359 | Crystalline form of cefamandole nafate compound, preparation and preparing method thereof | Aug 24, 2017 | Issued |
Array
(
[id] => 12660349
[patent_doc_number] => 20180111949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => NOVEL INDUSTRIAL CRYSTALLIZATION METHOD OF CEFUROXIME SODIUM AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/687377
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687377 | NOVEL INDUSTRIAL CRYSTALLIZATION METHOD OF CEFUROXIME SODIUM AND PREPARATION THEREOF | Aug 24, 2017 | Abandoned |
Array
(
[id] => 12219105
[patent_doc_number] => 20180057464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'PROCESSES FOR PREPARING OLAPARIB'
[patent_app_type] => utility
[patent_app_number] => 15/684222
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6841
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684222 | Processes for preparing olaparib | Aug 22, 2017 | Issued |
Array
(
[id] => 14624489
[patent_doc_number] => 20190225612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/326522
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326522 | 5-HT2C receptor agonists and compositions and methods of use | Aug 17, 2017 | Issued |
Array
(
[id] => 13051363
[patent_doc_number] => 10047062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Methods of chemical synthesis of Diaminophenothiazinium compounds including methylthioninium chloride (MTC)
[patent_app_type] => utility
[patent_app_number] => 15/674229
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18475
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674229
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674229 | Methods of chemical synthesis of Diaminophenothiazinium compounds including methylthioninium chloride (MTC) | Aug 9, 2017 | Issued |
Array
(
[id] => 12051136
[patent_doc_number] => 20170327479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'PROCESSES AND INTERMEDIATES FOR MAKING SWEET TASTE ENHANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/664179
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13894
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664179
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664179 | Processes and intermediates for making sweet taste enhancers | Jul 30, 2017 | Issued |
Array
(
[id] => 17126140
[patent_doc_number] => 20210300908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => S1P1 AGONIST AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/319491
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319491 | S1P1 agonist and application thereof | Jul 20, 2017 | Issued |
Array
(
[id] => 16735587
[patent_doc_number] => 10961222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/312666
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20006
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312666 | Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof | Jul 19, 2017 | Issued |
Array
(
[id] => 12117245
[patent_doc_number] => 20180000831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'NOVEL COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/651116
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24582
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651116 | Compound useful for the treatment of degenerative and inflammatory diseases | Jul 16, 2017 | Issued |
Array
(
[id] => 13196097
[patent_doc_number] => 10112958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides
[patent_app_type] => utility
[patent_app_number] => 15/646572
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41340
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 319
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646572 | N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides | Jul 10, 2017 | Issued |
Array
(
[id] => 16150345
[patent_doc_number] => 10708263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
[patent_app_type] => utility
[patent_app_number] => 15/645308
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25218
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645308
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645308 | Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders | Jul 9, 2017 | Issued |
Array
(
[id] => 13049223
[patent_doc_number] => 10045988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Spirocyclic compounds as tryptophan hydroxylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/645054
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119897
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645054
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645054 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Jul 9, 2017 | Issued |
Array
(
[id] => 13717053
[patent_doc_number] => 20170369481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => Bicyclic PKM2 Activators
[patent_app_type] => utility
[patent_app_number] => 15/645621
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645621 | Bicyclic PKM2 activators | Jul 9, 2017 | Issued |
Array
(
[id] => 13276567
[patent_doc_number] => 10149849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
[patent_app_type] => utility
[patent_app_number] => 15/641383
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36166
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15641383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/641383 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Jul 4, 2017 | Issued |
Array
(
[id] => 14993589
[patent_doc_number] => 20190315752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315438
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -113
[patent_words_short_claim] => 375
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315438 | Bicyclic urea kinase inhibitors and uses thereof | Jul 4, 2017 | Issued |
Array
(
[id] => 14929755
[patent_doc_number] => 20190300515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => 1,3, 5-Dioxazine Derivatives, Method of Preparation and Application Thereof as Sulfide Scavenger
[patent_app_type] => utility
[patent_app_number] => 16/349520
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349520
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349520 | 1,3,5-dioxazine derivatives, method of preparation and application thereof as sulfide scavenger | Jul 4, 2017 | Issued |